We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+0.12%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$306B
AUM Growth
+$4.93B
Cap. Flow
+$7.83B
Cap. Flow %
2.56%
Top 10 Hldgs %
17.03%
Holding
3,610
New
202
Increased
2,185
Reduced
922
Closed
109

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$269M
2
AMZN icon
Amazon
AMZN
+$242M
3
AAPL icon
Apple
AAPL
+$215M
4
AMGN icon
Amgen
AMGN
+$212M
5
CFG icon
Citizens Financial Group
CFG
+$193M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Financials 13.47%
3 Healthcare 12.09%
4 Consumer Discretionary 10.78%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCLI
3476
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$38K ﹤0.01%
752
UBX
3477
DELISTED
Unity Biotechnology
UBX
$38K ﹤0.01%
1,259
-13,099
-91% -$462K
BIOL
3478
DELISTED
Biolase, Inc.
BIOL
$38K ﹤0.01%
24
IZEA icon
3479
IZEA Worldwide
IZEA
$63.2M
$37K ﹤0.01%
4,753
ASAP
3480
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$37K ﹤0.01%
2,034
SREV
3481
DELISTED
ServiceSource International, Inc.
SREV
$37K ﹤0.01%
26,733
CATX icon
3482
Perspective Therapeutics
CATX
$354M
$35K ﹤0.01%
5,547
AREC icon
3483
American Resources Corp
AREC
$307M
$33K ﹤0.01%
17,208
OTIC
3484
DELISTED
Otonomy, Inc.
OTIC
$33K ﹤0.01%
16,843
VISL
3485
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$33K ﹤0.01%
899
JAGX icon
3486
Jaguar Health
JAGX
$3.83M
0
DOMH icon
3487
Dominari Holdings
DOMH
$70.6M
$31K ﹤0.01%
2,208
MARK
3488
DELISTED
Remark Holdings, Inc.
MARK
$31K ﹤0.01%
2,905
YCBD icon
3489
cbdMD
YCBD
$5.91M
$30K ﹤0.01%
40
OPTT icon
3490
Ocean Power Technologies
OPTT
$54.9M
$29K ﹤0.01%
12,445
GPUS
3491
Hyperscale Data Inc
GPUS
$55.4M
0
REED
3492
DELISTED
Reeds, Inc. Common Stock
REED
$29K ﹤0.01%
962
STAB
3493
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$29K ﹤0.01%
+12,170
New +$46.1K
AVGR
3494
DELISTED
Avinger, Inc. Common Stock
AVGR
$28K ﹤0.01%
121
PTN
3495
Palatin Technologies
PTN
$13.2M
$26K ﹤0.01%
46
CLIR icon
3496
ClearSign Technologies
CLIR
$26.5M
$25K ﹤0.01%
1,207
PHUN icon
3497
Phunware
PHUN
$43.8M
$25K ﹤0.01%
522
COMS
3498
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$25K ﹤0.01%
151
HYMC icon
3499
Hycroft Mining Holding Corp
HYMC
$2.49B
$22K ﹤0.01%
1,473
ADMA icon
3500
ADMA Biologics
ADMA
$2.23B
-58,927
Closed -$95K

Similar funds

Charles Schwab's Q3 2021 Portfolio in Review

As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
  • Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
  • Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
  • Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
  • Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
  • Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
  • Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.

Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.